Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine in Healthy Adults

NCT00664417 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00664417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine in Healthy Adults
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2008
Completion date
August 31, 2010
Enrollment
375 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, orthomyxoviridae infections